Literature DB >> 16389314

Animal models of generalized dystonia.

Robert S Raike1, H A Jinnah, Ellen J Hess.   

Abstract

Dystonia is a prevalent neurological disorder characterized by abnormal co-contractions of antagonistic muscle groups that produce twisting movements and abnormal postures. The disorder may be inherited, arise sporadically, or result from brain insult. Dystonia is a heterogeneous disorder because patients may exhibit focal or generalized symptoms associated with abnormalities in many brain regions including basal ganglia and cerebellum. Elucidating the pathogenic mechanisms underlying dystonia has therefore been challenging. Animal models of dystonia exhibit similar heterogeneity and are useful for understanding pathogenesis. The neurochemical and neurophysiological abnormalities in rodents with idiopathic generalized dystonia suggest that dysfunctional output from basal ganglia, cerebellum, or from multiple systems is the cause of motor dysfunction. Findings from drug- or toxin-induced dystonia in rodents and nonhuman primates mirror the genetic models. The parallels between dystonia in humans and animals suggest that the models will continue to prove useful in determining pathogenesis. Furthermore, detailed characterization of the existing models of dystonia and the development of new models hold promise for the identification of novel therapeutics.

Entities:  

Mesh:

Year:  2005        PMID: 16389314      PMCID: PMC1144494          DOI: 10.1602/neurorx.2.3.504

Source DB:  PubMed          Journal:  NeuroRx        ISSN: 1545-5343


  125 in total

1.  An allele of the mouse mutant dystonia musculorum exhibits lesions in red nucleus and striatum.

Authors:  A Messer; N L Strominger
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

2.  Cerebellar cell degeneration in the leaner mutant mouse.

Authors:  K Herrup; S L Wilczynski
Journal:  Neuroscience       Date:  1982       Impact factor: 3.590

3.  Spontaneous polyspike discharges in an epileptic mutant mouse (tottering).

Authors:  B J Kaplan; T N Seyfried; G H Glaser
Journal:  Exp Neurol       Date:  1979-12       Impact factor: 5.330

4.  Inherited epilepsy: spike-wave and focal motor seizures in the mutant mouse tottering.

Authors:  J L Noebels; R L Sidman
Journal:  Science       Date:  1979-06-22       Impact factor: 47.728

5.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

Authors:  J W Langston; P Ballard; J W Tetrud; I Irwin
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

6.  Alterations in cerebellar glutamic acid decarboxylase (GAD) activity in a genetic model of torsion dystonia (rat).

Authors:  G A Oltmans; M Beales; J F Lorden; J H Gordon
Journal:  Exp Neurol       Date:  1984-07       Impact factor: 5.330

7.  Decreased catalepsy response to haloperidol in the genetically dystonic (dt) rat.

Authors:  T W McKeon; J F Lorden; G A Oltmans; M Beales; S U Walkley
Journal:  Brain Res       Date:  1984-08-06       Impact factor: 3.252

8.  Spontaneous seizures: a new mutation in Syrian golden hamsters.

Authors:  C H Yoon; J S Peterson; D Corrow
Journal:  J Hered       Date:  1976 Mar-Apr       Impact factor: 2.645

9.  A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  R S Burns; C C Chiueh; S P Markey; M H Ebert; D M Jacobowitz; I J Kopin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

10.  Characterization of the rat mutant dystonic (dt): a new animal model of dystonia musculorum deformans.

Authors:  J F Lorden; T W McKeon; H J Baker; N Cox; S U Walkley
Journal:  J Neurosci       Date:  1984-08       Impact factor: 6.167

View more
  29 in total

1.  Effects of pharmacological entopeduncular manipulations on idiopathic dystonia in the dt(sz) mutant hamster.

Authors:  Melanie Hamann; Svenja E Sander; Annette Kreil; Angelika Richter
Journal:  J Neural Transm (Vienna)       Date:  2010-05-09       Impact factor: 3.575

Review 2.  Convergent mechanisms in etiologically-diverse dystonias.

Authors:  Valerie B Thompson; H A Jinnah; Ellen J Hess
Journal:  Expert Opin Ther Targets       Date:  2011-12-03       Impact factor: 6.902

3.  Microstructural white matter changes in primary torsion dystonia.

Authors:  Maren Carbon; Peter B Kingsley; Chengke Tang; Susan Bressman; David Eidelberg
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

4.  Increased cerebellar activation during sequence learning in DYT1 carriers: an equiperformance study.

Authors:  Maren Carbon; Maria Felice Ghilardi; Miklos Argyelan; Vijay Dhawan; Susan B Bressman; David Eidelberg
Journal:  Brain       Date:  2007-10-18       Impact factor: 13.501

Review 5.  Engineering animal models of dystonia.

Authors:  Janneth Oleas; Fumiaki Yokoi; Mark P DeAndrade; Antonio Pisani; Yuqing Li
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

Review 6.  The functional neuroanatomy of dystonia.

Authors:  Vladimir K Neychev; Robert E Gross; Stephane Lehéricy; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2011-02-12       Impact factor: 5.996

Review 7.  Pathological basal ganglia activity in movement disorders.

Authors:  T Wichmann; J O Dostrovsky
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

8.  Antidystonic effects of Kv7 (KCNQ) channel openers in the dt sz mutant, an animal model of primary paroxysmal dystonia.

Authors:  A Richter; S E Sander; C Rundfeldt
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

9.  Mammalian diseases of phosphatidylinositol transfer proteins and their homologs.

Authors:  Aaron H Nile; Vytas A Bankaitis; Aby Grabon
Journal:  Clin Lipidol       Date:  2010-12-01

10.  Low-frequency oscillations in the cerebellar cortex of the tottering mouse.

Authors:  Gang Chen; Laurentiu S Popa; Xinming Wang; Wangcai Gao; Justin Barnes; Claudia M Hendrix; Ellen J Hess; Timothy J Ebner
Journal:  J Neurophysiol       Date:  2008-11-05       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.